Related Experiment Video
Updated: Feb 2, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Enzyme Replacement Therapy in Pregnant Women with Fabry Disease: A Case Series
Pehuén Fernández1, Shunko Oscar Fernández2, Jacqueline Griselda Mariela Gonzalez2
1CIDTEF, Centro de Investigación, Diagnóstico y Tratamiento de Enfermedad de Fabry (Research, Diagnosis and Treatment Center for Fabry Disease), San Fernando del Valle de Catamarca, Argentina. pehuenfernandez@hotmail.com.
Abstract:
Fabry disease is a rare inherited lysosomal storage disorder caused by the deficiency of the enzyme alpha-galactosidase A. There is uncertainty regarding the safety of enzyme replacement therapy during pregnancy. We describe the course and outcome of seven pregnancies in six patients with Fabry disease who continued or reinitiated enzyme replacement therapy during pregnancy. No adverse events, in both mothers and children, were observed.
More Related Videos
08:07Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions
Published on: May 26, 2023
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme Kinetics
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
Gene Therapy
Resistors In Series
In a series circuit, the...